We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ultrasound Could Help Determine Fetuses at Increased Risk for Stillbirth

By HospiMedica International staff writers
Posted on 17 Jul 2012
The smallest and the heaviest fetuses are at much higher risk of being stillborn than those of average weight, new ultrasound-imaging research has found. More...


Fetuses who are “severely small for gestational age,” or weigh below the bottom one percentile of all fetuses, disproportionately account for about 6% of all stillbirths, according to Canadian researchers. Fetuses that are “severely large for gestational age,” or weigh above the 99th percentile, account for nearly 1% of stillbirths.

“In this study of all registered live-born and stillborn infants in Ontario, extreme underweight and overweight states confer the highest risk of stillbirth,” said Drs. Joel Ray and Marcelo Urquia, from St. Michael’s Hospital (Toronto, Ontario, Canada), and authors of the article that was published in the July 2012 issue of the Journal of Perinatology.

Stillbirth is conventionally defined as the death of a fetus at more than 23 weeks of gestation weighing 500 g or more. However, Drs. Ray and Urquia included infants born beginning as early as 20 weeks of gestation on the grounds that maternal-fetal bonding is well established at that point, since most mothers-to-be have undergone a level 2 ultrasound detailing the unborn infant’s developing bones and organs.

Including those infants provides new data about the level to which low and high weights are linked with stillbirths, including those before the point of viability, according to Dr. Ray. That, then, may help clinicians better decide at which time it is better to allow a pregnancy to continue so the fetus can grow, or to deliver a premature baby who might otherwise die in the womb.

The rate of stillbirths in industrialized countries is approximately six per 1,000, of which half occur after 27 weeks of gestation. In poorer countries, the rate is up to five times higher. Stillbirths are more common than the death of a baby after birth, such as from prematurity or because of sudden infant death syndrome (SIDS). However, stillbirths have mostly been overlooked by medical professionals, especially in terms of their emotional effect on the mother, her partner, and extended family, according to Dr. Ray.

The researchers examined records of all 767,016 live births and all 4,697 stillbirths in Ontario between 2002 and 2007. They noted that because they looked at so many births, they could also make statistically precise estimations of the impact of extremely low birth weight on the risk of stillbirth.

The investigators discovered that 19% of stillbirths occur in fetuses under the tenth percentile of weight. But being below the first percentile of weight meant the fetus faced a 9.5 times higher risk of being stillborn than infants who are within the average weight range, between the 40th to 60th weight percentiles. Dr. Ray reported that when fetuses are severely small for gestational age, it typically means there is a problem with the placenta. Fetuses who are acutely large for gestational age are usually so because of the mom having diabetes or obesity.

The authors concluded that since more than 95% of women in the industrialized world receive a level 2 anatomic ultrasound scan before 22 weeks gestation, fetal weight should be estimated and reported at this time of the ultrasound, as a standard practice. In doing so, the early presence of a small or large fetus may help guide ongoing ultrasound monitoring for growth and well-being.

Related Links:

St. Michael’s Hospital




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.